Pharmaceutical Executive September 19, 2022
Pharmaceutical Executive Editorial Staff

Pharm Exec sat down with Rohit Gupta, to discuss how biopharma companies can revamp their commercial strategies to account for the increasingly complex prescribing environment in a rapidly consolidating health care industry.

Pharmaceutical Executive: Consolidation in the health care industry isn’t a new trend, but the move of physicians from independent practices to large hospital systems seems to be accelerating. What’s going on?

Rohit Gupta: There are several factors at play here. But you are right. This is an undeniable trend, and one biopharma must grapple with to improve commercial effectiveness. A study from the Physicians Advocacy Institute and Avalere Health found that nearly 70% of physicians are now employed by hospitals or corporations.

Some of this can be chalked...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Interview / Q&A, Pharma, Pharma / Biotech, Provider, Trends
Brazil’s plan for low-cost CAR-Ts
PacBio’s Repeat Expansion Panel, Owkin-Sanofi AI Take on Immunology, More
STAT+: Borrowing an idea from cancer immunotherapy, scientists make old-mice immune systems youthful again
Moderna gets Blackstone backing for flu vaccine R&D
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension

Share This Article